Can VEGF-B Be Used to Treat Neurodegenerative Diseases?

QR Code

Can VEGF-B Be Used to Treat Neurodegenerative Diseases?

None

Saved in:

Bibliographic Details
Main Authors:	Li, Xuri, Kumar, Anil, Lee, Chunsik, Tang, Zhongshu, Li, Yang, Arjunan, Pachiappan, Hou, Xu, Zhang, Fan
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24858
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combined Therapies to Treat CNV in AMD: PDT + Anti-VEGF
by: Mataix, Jorge, et al.
Published: (2012)

Embryonic Stem Cell in the Therapy of Neurodegenerative Diseases
by: Fan, Xiaotang, et al.
Published: (2011)

Exercise-induced neurogenesis through BDNF-TrkB pathway: implications for neurodegenerative disorders
by: Lee Jun Jie, et al.
Published: (2025-02-01)

Novel targets for treating neurodegenerative diseases: The PKM2-STAT3-hnRNPA1 feedback loop
by: Ping Ye, et al.
Published: (2025-08-01)

Potential common pathogenesis of several neurodegenerative diseases
by: Ting Fan, et al.
Published: (2026-03-01)

Which B2 Fractures Can Be Treated with ORIF? Validation of the “Beyond the Vancouver Classification”
by: Karl Stoffel, et al.
Published: (2025-06-01)

Pathology of Neurodegenerative Diseases
by: Kim, YoungSoo, et al.
Published: (2012)

Nanoparticle delivery of VEGF-B mRNA promotes T cell infiltration within tumor and triggers robust antitumor immunity
by: Geqiang Zhang, et al.
Published: (2025-09-01)

The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases
by: Sharma Anurag, et al.
Published: (2025-06-01)

Predictive levels of vascular endothelial growth factor (VEGF), thymidine kinase 1 (TK1) with interleukin-6 (IL-6), plasma T cells, NK cells as well as B cells in treating diffuse large B-cell lymphoma receiving rituximab
by: Tian Lihua, et al.
Published: (2025-01-01)

The Role of VEGF in the Process of Neovasculogenesis
by: Sobczyńska-Rak, Aleksandra
Published: (2012)

Role of Astrocytes in Neurodegenerative Diseases
by: Barreto, George E., et al.
Published: (2011)

Microglia, Calcification and Neurodegenerative Diseases
by: Vidal-Taboada, Jose M., et al.
Published: (2011)

Oxidative Stress and Neurodegenerative Disease
by: Rivas-Arancibia, Selva, et al.
Published: (2011)

Association of vascular endothelial growth factor B (VEGFВ) gene polymorphisms with intracranial aneurysms
by: R. I. Sultanova, et al.
Published: (2019-01-01)

Interplay between circadian rhythm, ageing and neurodegenerative disorder
by: Aarti Nagayach, et al.
Published: (2025-07-01)

Ferroptosis in neurodegenerative diseases: potential mechanisms of exercise intervention
by: Shaokai Tang, et al.
Published: (2025-06-01)

Using EEG Signals and AI to Predict Neurodegenerative Diseases
by: Juan Li, et al.
Published: (2025-01-01)

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential
by: Yingxuan Yan, et al.
Published: (2025-08-01)

VEGF Targeting Agents in Ovarian Cancer
by: Mabuchi, Seiji, et al.
Published: (2012)

Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases
by: Gang Wang, et al.
Published: (2025-07-01)

Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol
by: Lucia Saucedo, PhD, et al.
Published: (2025-11-01)

RETRACTED ARTICLE: Long non-coding RNA CCAT2 acts as an oncogene in osteosarcoma through regulation of miR-200b/VEGF
by: Juntao Liu, et al.
Published: (2019-12-01)

NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies
by: Keyi Zhang, et al.
Published: (2025-07-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma
by: Jiehui Di, et al.
Published: (2017-07-01)

Genome Profiling and Potential Biomarkers in Neurodegenerative Disorders
by: Lovrečić, Luca, et al.
Published: (2011)

Analysis of the Impact of CD200 on Neurodegenerative Diseases
by: Miller, Anne-Marie, et al.
Published: (2011)

ASK1 and Its Role in Neurodegenerative Diseases
by: Sturchler, Emmanuel, et al.
Published: (2011)

Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
by: Abdul Haque, et al.
Published: (2025-01-01)

Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases
by: Renata Kołodziejska, et al.
Published: (2025-07-01)

Editorial: Neuroimaging in psychiatry 2023: neurodegenerative disorders
by: Jannik Prasuhn, et al.
Published: (2025-07-01)

Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats
by: O. V. Shcheblykina, et al.
Published: (2025-06-01)

Vitamin B12 status in metformin treated patients: systematic review.
by: Qilin Liu, et al.
Published: (2014-01-01)

Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases
by: Min Zhou, et al.
Published: (2026-04-01)

Investigation of the temporal distribution of anti-VEGF drugs in the retina and the correlation with the distribution of FcR isoforms
by: Jicai He, et al.
Published: (2025-11-01)

Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis.
by: Xinghua Xu, et al.
Published: (2015-01-01)

The level of VEGF-A in the lacrimal fluid of diabetic retinopathy
by: Yu. A. Borzilova, et al.
Published: (2015-12-01)

Cerebrotendinous xanthomatosis: A rare neurodegenerative disorder with characteristic imaging findings
by: Hamza Ghazali Khan, MBBS, et al.
Published: (2025-09-01)

Variants and Polymorphisms of DNA Repair Genes and Neurodegenerative Diseases
by: Coppede, Fabio
Published: (2011)